DECEMBER 2023LIFE SCIENCES REVIEW5IN MY OPINION08CXO INSIGHTSLAST WORD18Peter Hesse,Vice President Head of Genomics Business,QIAGENUnlocking the potential of next-generation sequencing22Sofie Stille,Vice President of Technology,CytivaThe Next Technological Advancement in Resin Development20Gerd Möller,MD, PhD, Health Economist (ebs),Medical Director European Partner Markets (EPM),Medison Pharma Trading AGMedical Affairs: A Powerhouse to Accelerate Access of Innovative Therapies to Patients in Countries Around the WorldRüdiger Schulze,Vice President and General Manager, DACHUltragenyxEstablishing a Biotech company in Europe:A mission impossible?Léa Sorret,principal Scientist & Group Lead in Pharmaceutical Development,Lonza Drug Product ServicesConsiderations for Clinical In-Use Testing of Biotherapeutics24Anita Nelsen,Senior Vice President,Clinical Trial Operations,Patient-Centric Approach to Accelerating Clinical Trials26Elliot Neto,Ruminant Technical Service Manager,Kemin IndustriesTechnology is Accelerating Change in the Biotech Sector2830Leveraging Data Analytics for Enhanced Food Safety and Quality ControlDr. Christine Hilbert,use this: Senior Marketing Technical Writer,Hygiena
< Page 4 | Page 6 >